Intellectual Property Repository

The Repository for Intellectual Property (IP) is a separate legal entity, often with off-shore ownership, whose mission it is to safeguard the intellectual property of the corporation as developed by affiliates. The corporation (indirectly) controls IP developed using its funding, unless stipulated to the contrary in the funding agreement. This IP includes all the laboratory and clinical research data developed by corporate-funded affiliates. It includes all the transcripts, documentation, videos, and other digital evidence collected during formal decisions (e.g., Trial by Jury+) on affiliate products (e.g., prototypes). Most IP developed using the funds of the corporation eventually finds its way into the repository.

The Repository has several objectives. It protects IP from prying eyes: it’s a separate legal entity that builds a firewall+ between the intellectual property (i.e., as evidence), and any trial lawyers going after the corporation’s deep pockets. It protects the corporation from unscrupulous individuals working in prototype development: we can and will use information in the repository to track down stolen intellectual property. It’s an information repository for vendors seeking to develop proposals and bids to work on prototypes or commercialization+ of prototypes: we provide comprehensive access to research data to potential vendor-partners, subject to strict confidentiality agreements.

The Repository for Intellectual Property (IP) stores information in electronic format. This IP is mostly collected electronically, perhaps using a technology like the electronic smart pen LiveScribe™. Electronic data is uploaded, and original copies are erased from affiliate storage mediums on a scheduled basis. Non-digital documents are scanned, stored and destroyed.

The repository is simply there to safeguard the data as it is captured in its raw form. It makes no attempt at harmonization, rationalization, sanitation, optimization or ‘knowledge management’ of the IP. It does not promote knowledge sharing, one of the designated Worst Practices+, except to the extent that certain items can be tagged for searching by potential vendor-partners. The repository is very cost-effective, pennies per gigabyte.


Vendor-partners bidding to provide commercialization services for a prototype typically have access to a wide variety of documentation from the repository:

  • Prototype laboratory and clinical data, including reports, analyses and decision transcripts
  • Trial by Jury transcripts, digital evidence, video captures
  • Due diligence documentation and other records of purchase of the prototype by the firm
  • Previous solicitations, bids and proposals by vendors concerning the prototype.

We capture to the best of our ability all the explicit information concerning the prototype. This repository is the foundational basis of our ability to request a free-format proposal+ from our vendors. We provide our vendors all the information they need to succeed.

The information is very sensitive, owned by a separate legal entity, and typically only accessible from a well-guarded safe room. Electronic copies of repository IP are tightly controlled. Repository IP is not available on inter or intranet computers. This is not an electronic archive in the common sense of the term. This is protection of IP.